[1]
|
J. M. Alustiza , A. Castiella, M. D. De Juan, J. I. Emparanza, J. Artetxe, et al., “Iron Overload in the Liver Diagnostic and Quantification,” European Journal of Radiology, Vol. 61, No. 3, 2007, pp. 499-506.
doi:10.1016/j.ejrad.2006.11.012
|
[2]
|
J. C. Wood, C. Enriquez, N. Ghugre, J. M. Tyzka, S. Carson, M. D. Nelson, et al., “MRI R2 and R2* Mapping Accurately Estimates Hepatic Iron Concentration in Transfusion-Dependent Thalassemia and Sickle Cell Disease Patients,” Blood, Vol. 106, No. 4, 2005, 1460-1465.
doi:10.1182/blood-2004-10-3982
|
[3]
|
T. G. He, P. D. Gatehouse, L. J. Anderson, et al., “Development of a Novel Optimized Breathhold Technique for Myocardial T2 Measurement in Thalassemia,” Journal of Magnetic Resonance Imaging, Vol. 24, No. 3, 2006, pp. 580-585.
|
[4]
|
T. G. Maris, O. Papakonstantinou, V. Chatzimanoli, A. Papadakis, et al., “Myocardial and Liver Iron Status Using a Fast T*2 Quantitative MRI (T*2qMRI) Technique,” Magnetic Resonance in Medicine, Vol. 57, No. 4, 2007, pp. 742-753. doi:10.1002/mrm.21204
|
[5]
|
E. Angelucci, G. M. Brittenham, C. E. McLaren, M. Ripalti, D. Baronciani, et al., “Hepatic Iron Concentration and Total Body Iron Store in Thalassemia Major,” New England Journal of Medicine, Vol. 343, No. 5, 2000, pp. 327331.
|
[6]
|
V. Positano, B. Salani, A. Pepe, M. F. Santarelli, D. De Marchi, A. Ramazzotti, et al., “Improved T2* Assessment in Liver Iron Overload by Magnetic Resonance Imaging,” Magnetic Resonance Imaging, Vol. 27, No. 2, 2009, pp. 188-197. doi:10.1016/j.mri.2008.06.004
|
[7]
|
E. Alexopoulou, F. Stripeli, P. Baras, I. Seimenis, et al., “R2 Relaxometry with MRI for the Quantification of Tissue Iron Overload in β-Thalassemic Patients,” Journal of Magnetic Resonance Imaging, Vol. 23, No. 2, 2006, pp. 163-170.
|
[8]
|
A. Christoforidis, A. Haritandi, I. Tsitouridis, I. Tsatra, et al., “Correlative Study of Iron Accumulation in Liver, Myocardium, and Pituitary Assessed with MRI in Young Thalassemic Patients,” Journal of Pediatric Hematology/ Oncology, Vol. 28, No. 5, 2006, pp. 311-315.
doi:10.1097/01.mph.0000212915.22265.3b
|
[9]
|
M. A Tanner, T. G. He, M. A. Westwood and D. N. Firmin, “Multi-Center Validation of the Transferability of the Magnetic Resonance T2* Technique for the Quantification of Tissue Iron,” Haematologica, Vol. 91, No. 10, 2006, pp. 1388-1391.
|
[10]
|
M. I. Argyropoulou and L. Astrakas, “MRI Evaluation of Tissue Iron Burden in Patients with β-Thalassaemia Major,” Pediatric Radiology, Vol. 37, No. 12, 2007, pp. 1191-1200. doi:10.1007/s00247-007-0567-1
|
[11]
|
J. C. Wood, M. Otto-Duessel, M. Aguilar, H. Nick, M. D. Nelson, T. D. Coates, et al., “Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy,” Circulation, Vol. 112, No. 4, 2005, pp. 535-543. doi:10.1161/CIRCULATIONAHA.104.504415
|
[12]
|
T. G. St. Pierre, P. R. Clark, W. Chua-Anusorn, A. J. Fleming, G. P. Jeffrey, et al., “Noninvasive Measurement and Imaging of Liver Iron Concentrations Using Proton Magnetic Resonance,” Blood, Vol. 105, No. 2, 2005, pp. 855861. doi:10.1182/blood-2004-01-0177
|
[13]
|
L. J. Anderson, S. Holden, B. Davis, E. Prescott, C. C. Charrier, N. H. Bunce, et al., “Cardiovascular T2-Star (T2*) Magnetic Resonance for the Early Diagnosis of Myocardial Iron Overload,” European Heart Journal, Vol. 22, No. , 2001, pp. 2171-2179. doi:10.1053/euhj.2001.2822
|
[14]
|
A. Pepe, M. Lombardi, V. Positano, E. Cracolici, M. Capra, et al., “Evaluation of the Efficacy of Oral Deferiprone in β-Thalassemia Major by Multislice Multiecho T2*,” European Journal of Haematology, Vol. 76, No. 3, 2006, pp. 183-192.
|
[15]
|
C. Rossi, A. Boss, M. Haap, P. Martirosian, et al., “WholeBody T2* Mapping at 1.5 T,” Magnetic Resonance Imaging, Vol. 27, No. 4, 2009, pp. 489-496.
doi:10.1016/j.mri.2008.08.004
|
[16]
|
H. Soltanian-Zadeh, D. J. Peck, D. O. Hearshen and R. R. Lajiness-O’Neill, “Model-Independent Method for fMRI Analysis,” IEEE Transactions on Medical Imaging, Vol. 23, No. 3, 2004, pp. 285-296.
doi:10.1109/TMI.2003.823064
|
[17]
|
R. T. Song, A. R. Cohen and H. K. Song, “Improved Transverse Relaxation Rate Measurement Techniques for the Assessment of Hepatic and Myocardial Iron Content,” Journal of Magnetic Resonance Imaging, Vol. 26, No. 1, 2007, pp. 208-214. doi:10.1002/jmri.20994
|
[18]
|
M. Westwood, L. J. Anderson, D. N. Firmin, et al., “A Single Breath-Hold Multiecho T2* Cardiovascular Magnetic Resonance Technique for Diagnosis of Myocardial Iron Overload,” Journal of Magnetic Resonance Imaging, Vol. 18, No. 1, 2003, pp. 33-39.
|
[19]
|
S. Mavrogeni, E. Gotsis, V. Ladis, E. Berdousis, et al., “Magnetic Resonance Evaluation of Liver and Myocardial Iron Deposition in Thalassemia Intermedia and βThalassemia Major,” International Journal of Cardiovascular Imaging, Vol. 24, No. 8, 2008, pp. 849-854.
|
[20]
|
S. Mavrogeni, E. D. Gotsis, E. Berdousi, V. Ladis, et al., “Myocardial and Hepatic T2* Magnetic Resonance Evaluation in Ex-Thalassemic Patients after Bone-Marrow Transplantation,” International Journal of Cardiovascular Imaging, Vol. 23, No. 6, 2007, pp. 739-745.
doi:10.1007/s10554-006-9203-7
|
[21]
|
E. Angelucci, P. Muretto, A. Nicolucci, et al., “Effects of Iron Overload and Hepatitis C Virus Positivity in Determining Progression of Liver Fibrosis in Thalassemia Following Bone Marrow Transplantation,” Blood, Vol. 100, No. 1, 2002, pp. 17-21.
|
[22]
|
A. W. Olthof, P. E. Sijens, H. G. Kreeftenberg, et al., “Non-Invasive Liver Iron Concentration Measurement by MRI, Comparison of Two Validated Protocols,” European Journal of Radiology, Vol. 71, No. 1, 2009, pp. 116-121.
|